CPI adds TrialMaster EDC tech to offering

By Staff Reporter

- Last updated on GMT

Related tags: Customer service

German CRO Clinicalprojects International (CPI) will begin providing its customers with the TrialMaster EDC solution though a deal with developer OmniComm.

The emergence of new trial centres worldwide, coupled with the increasing pharma industry trend to conduct trials in partnership with CROs at multiple sites, has seen electronic data capture (EDC) become a necessity.

The TrialMaster system is available to contract research organisations (CRO) that participate in US software firm OmniComm’s “preferred programme,” which also provides a dedicated, hosted environment and comprehensive training.

"At CPI we have had the opportunity to become familiar with many of the EDC systems available today. We have chosen to work with the OmniComm team because of their dedication to providing the best in industry customer service and for their superior EDC product TrialMaster,"​ said Joerg W. Breitkopf, Managing Director of CPI.

"We are strong believers in cooperation and teamwork. With the assistance of our alliances' network and international partnerships, we are able to broaden our services and our global presence and offer superior products and services to our customers​."

The collaboration, financial terms of which have not been made public, will be co-ordinated by OmniComm’s team in Bonn, Germany as OmniComm COO Stephen Johnson explained.

"Our CRO Preferred program continues to expand internationally and the significant industry experience of our team in Bonn, has allowed us to deliver the high quality customer service that our customers require.”

Johnson added that the "program offers members substantial benefits such as the fixed pricing and complete marketing support that other vendors simply cannot compete with. Partnering with OmniComm allows CROs to offer their customers a first class EDC product with predictable pricing that gives them a competitive edge​."

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us


View more